J&J R&D vet Peter Tummino joins the Big Pharma exodus, leaping to Nimbus as CSO; Cadent taps Jodie Morrison for CEO
→ After spending the last 16 years as a researcher in Big Pharma, Peter Tummino is going biotech.
Nimbus reports that Tummino is joining the company as its new CSO after his last stint at J&J, where he was global head of lead discovery and headed up research teams on both sides of the Atlantic. Earlier he had a long stretch at GSK, where he ran the cancer epigenetics team, among other things.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.